APO Research

APO RESEARCH · REPORT

Calming and Sleeping

Selected research

Industry Growth & Trends

Global Calming and Sleeping Industry Growth and Trends Forecast to 2032

Market perspective

The global Calming and Sleeping market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Calming and Sleeping include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Calming and Sleeping market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Calming and Sleeping market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Calming and Sleeping market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Calming and Sleeping.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Calming and Sleeping market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Calming and Sleeping Market by Company

Teva Pharmaceutical

Johnson & Johnson

Eli Lilly

AstraZeneca

Sunovion Pharmaceuticals

Roscoe Medical

Durect

Collegium Pharmaceutical

Cara Therapeutics

Acura Pharmaceuticals

Calming and Sleeping Segment by Type

Medications

Sleep Laboratories

Sleep Apnea Devices

Mattresses and Pillows

Prescriptions

Over-The-Counter (OTC)

Calming and Sleeping Segment by Application

Restless Leg Syndrome (RLS)

Narcolepsy

Sleepwalking

Bruxism

Insomnia

Sleep apnea

Calming and Sleeping Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Medications Table 2. Major Company of Sleep Laboratories Table 3. Major Company of Sleep Apnea Devices Table 4. Major Company of Mattresses and Pillows Table 5. Major Company of Prescriptions Table 6. Major Company of Over-The-Counter (OTC) Table 7. Global Calming and Sleeping Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 9. Global Calming and Sleeping Sales Market Share in Volume by Type (2021-2026) Table 10. Global Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 11. Global Calming and Sleeping Sales Market Share in Value by Type (2021-2026) Table 12. Global Calming and Sleeping Price by Type (2021-2026) & (US$/Unit) Table 13. Global Calming and Sleeping Sales by Type (2027-2032) & (K Units) Table 14. Global Calming and Sleeping Sales Market Share in Volume by Type (2027-2032) Table 15. Global Calming and Sleeping Sales by Type (2027-2032) & (US$ Million) Table 16. Global Calming and Sleeping Sales Market Share in Value by Type (2027-2032) Table 17. Global Calming and Sleeping Price by Type (2027-2032) & (US$/Unit) Table 18. North America Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 19. North America Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 21. Europe Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 25. Latin America Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Calming and Sleeping Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Calming and Sleeping Sales by Type (2021-2026) & (US$ Million) Table 28. Calming and Sleeping Industry Trends Table 29. Calming and Sleeping Industry Drivers Table 30. Calming and Sleeping Industry Opportunities and Challenges Table 31. Calming and Sleeping Industry Restraints Table 32. Global Calming and Sleeping Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Calming and Sleeping Revenue Market Share by Company (2021-2026) Table 34. Global Calming and Sleeping Sales by Company (2021-2026) & (K Units) Table 35. Global Calming and Sleeping Sales Share by Company (2021-2026) Table 36. Global Calming and Sleeping Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Calming and Sleeping Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Calming and Sleeping Major Company Production Sites and Headquarters Table 39. Global Calming and Sleeping Company, Product Type & Application Table 40. Global Calming and Sleeping Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Calming and Sleeping by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Calming and Sleeping Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Calming and Sleeping Sales by Region (2021-2026) & (K Units) Table 45. Global Calming and Sleeping Sales Market Share in Volume by Region (2021-2026) Table 46. Global Calming and Sleeping Sales by Region (2021-2026) & (US$ Million) Table 47. Global Calming and Sleeping Sales Market Share in Value by Region (2021-2026) Table 48. Global Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Calming and Sleeping Sales by Region (2027-2032) & (K Units) Table 50. Global Calming and Sleeping Sales Market Share in Volume by Region (2027-2032) Table 51. Global Calming and Sleeping Sales by Region (2027-2032) & (US$ Million) Table 52. Global Calming and Sleeping Sales Market Share in Value by Region (2027-2032) Table 53. Global Calming and Sleeping Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Calming and Sleeping Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 56. Global Calming and Sleeping Sales Market Share in Volume by Application (2021-2026) Table 57. Global Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 58. Global Calming and Sleeping Sales Market Share in Value by Application (2021-2026) Table 59. Global Calming and Sleeping Price by Application (2021-2026) & (US$/Unit) Table 60. Global Calming and Sleeping Sales by Application (2027-2032) & (K Units) Table 61. Global Calming and Sleeping Sales Market Share in Volume by Application (2027-2032) Table 62. Global Calming and Sleeping Sales by Application (2027-2032) & (US$ Million) Table 63. Global Calming and Sleeping Sales Market Share in Value by Application (2027-2032) Table 64. Global Calming and Sleeping Price by Application (2027-2032) & (US$/Unit) Table 65. North America Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 66. North America Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 68. Europe Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 72. Latin America Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Calming and Sleeping Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Calming and Sleeping Sales by Application (2021-2026) & (US$ Million) Table 75. Teva Pharmaceutical Company Information Table 76. Teva Pharmaceutical Business Overview Table 77. Teva Pharmaceutical Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Teva Pharmaceutical Calming and Sleeping Product Portfolio Table 79. Teva Pharmaceutical Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Johnson & Johnson Calming and Sleeping Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. Eli Lilly Company Information Table 86. Eli Lilly Business Overview Table 87. Eli Lilly Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Eli Lilly Calming and Sleeping Product Portfolio Table 89. Eli Lilly Recent Development Table 90. AstraZeneca Company Information Table 91. AstraZeneca Business Overview Table 92. AstraZeneca Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AstraZeneca Calming and Sleeping Product Portfolio Table 94. AstraZeneca Recent Development Table 95. Sunovion Pharmaceuticals Company Information Table 96. Sunovion Pharmaceuticals Business Overview Table 97. Sunovion Pharmaceuticals Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio Table 99. Sunovion Pharmaceuticals Recent Development Table 100. Roscoe Medical Company Information Table 101. Roscoe Medical Business Overview Table 102. Roscoe Medical Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Roscoe Medical Calming and Sleeping Product Portfolio Table 104. Roscoe Medical Recent Development Table 105. Durect Company Information Table 106. Durect Business Overview Table 107. Durect Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Durect Calming and Sleeping Product Portfolio Table 109. Durect Recent Development Table 110. Collegium Pharmaceutical Company Information Table 111. Collegium Pharmaceutical Business Overview Table 112. Collegium Pharmaceutical Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Collegium Pharmaceutical Calming and Sleeping Product Portfolio Table 114. Collegium Pharmaceutical Recent Development Table 115. Cara Therapeutics Company Information Table 116. Cara Therapeutics Business Overview Table 117. Cara Therapeutics Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Cara Therapeutics Calming and Sleeping Product Portfolio Table 119. Cara Therapeutics Recent Development Table 120. Acura Pharmaceuticals Company Information Table 121. Acura Pharmaceuticals Business Overview Table 122. Acura Pharmaceuticals Calming and Sleeping Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Acura Pharmaceuticals Calming and Sleeping Product Portfolio Table 124. Acura Pharmaceuticals Recent Development Table 125. North America Calming and Sleeping Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. North America Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 127. North America Calming and Sleeping Sales Market Share by Country (2021-2026) Table 128. North America Calming and Sleeping Sales Forecast by Country (2027-2032) & (K Units) Table 129. North America Calming and Sleeping Sales Market Share Forecast by Country (2027-2032) Table 130. North America Calming and Sleeping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Calming and Sleeping Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Calming and Sleeping Market Share by Country (2021-2026) Table 133. North America Calming and Sleeping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Calming and Sleeping Market Share Forecast by Country (2027-2032) Table 135. Europe Calming and Sleeping Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Europe Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 137. Europe Calming and Sleeping Sales Market Share by Country (2021-2026) Table 138. Europe Calming and Sleeping Sales Forecast by Country (2027-2032) & (K Units) Table 139. Europe Calming and Sleeping Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Calming and Sleeping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Calming and Sleeping Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Calming and Sleeping Market Share by Country (2021-2026) Table 143. Europe Calming and Sleeping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Calming and Sleeping Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Calming and Sleeping Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 147. Asia-Pacific Calming and Sleeping Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Calming and Sleeping Sales Forecast by Country (2027-2032) & (K Units) Table 149. Asia-Pacific Calming and Sleeping Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Calming and Sleeping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Calming and Sleeping Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Calming and Sleeping Market Share by Country (2021-2026) Table 153. Asia-Pacific Calming and Sleeping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Calming and Sleeping Market Share Forecast by Country (2027-2032) Table 155. Latin America Calming and Sleeping Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Latin America Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 157. Latin America Calming and Sleeping Sales Market Share by Country (2021-2026) Table 158. Latin America Calming and Sleeping Sales Forecast by Country (2027-2032) & (K Units) Table 159. Latin America Calming and Sleeping Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Calming and Sleeping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Calming and Sleeping Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Calming and Sleeping Market Share by Country (2021-2026) Table 163. Latin America Calming and Sleeping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Calming and Sleeping Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Calming and Sleeping Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Calming and Sleeping Sales by Country (2021-2026) & (K Units) Table 167. Middle East and Africa Calming and Sleeping Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Calming and Sleeping Sales Forecast by Country (2027-2032) & (K Units) Table 169. Middle East and Africa Calming and Sleeping Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Calming and Sleeping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Calming and Sleeping Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Calming and Sleeping Market Share by Country (2021-2026) Table 173. Middle East and Africa Calming and Sleeping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Calming and Sleeping Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Calming and Sleeping Distributors List Table 178. Calming and Sleeping Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Calming and Sleeping Image Figure 2. Global Calming and Sleeping Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calming and Sleeping Market Size (2021-2032) & (US$ Million) Figure 4. Global Calming and Sleeping Sales (2021-2032) & (K Units) Figure 5. Medications Image Figure 6. Global Medications Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sleep Laboratories Image Figure 8. Global Sleep Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 9. Sleep Apnea Devices Image Figure 10. Global Sleep Apnea Devices Sales YoY Growth (2021-2032) & (K Units) Figure 11. Mattresses and Pillows Image Figure 12. Global Mattresses and Pillows Sales YoY Growth (2021-2032) & (K Units) Figure 13. Prescriptions Image Figure 14. Global Prescriptions Sales YoY Growth (2021-2032) & (K Units) Figure 15. Over-The-Counter (OTC) Image Figure 16. Global Over-The-Counter (OTC) Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Calming and Sleeping Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Calming and Sleeping Market Share by Type 2025 VS 2032 Figure 19. North America Calming and Sleeping Sales Market Share in Volume by Type in 2025 Figure 20. North America Calming and Sleeping Sales Market Share in Value by Type in 2025 Figure 21. Europe Calming and Sleeping Sales Market Share in Volume by Type in 2025 Figure 22. Europe Calming and Sleeping Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Calming and Sleeping Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Calming and Sleeping Sales Market Share in Value by Type in 2025 Figure 25. Latin America Calming and Sleeping Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Calming and Sleeping Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Calming and Sleeping Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Calming and Sleeping Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Calming and Sleeping Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Restless Leg Syndrome (RLS) Image Figure 32. Global Restless Leg Syndrome (RLS) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Narcolepsy Image Figure 34. Global Narcolepsy Sales YoY Growth (2021-2032) & (K Units) Figure 35. Sleepwalking Image Figure 36. Global Sleepwalking Sales YoY Growth (2021-2032) & (K Units) Figure 37. Bruxism Image Figure 38. Global Bruxism Sales YoY Growth (2021-2032) & (K Units) Figure 39. Insomnia Image Figure 40. Global Insomnia Sales YoY Growth (2021-2032) & (K Units) Figure 41. Sleep apnea Image Figure 42. Global Sleep apnea Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Calming and Sleeping Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Calming and Sleeping Market Share by Application 2025 VS 2032 Figure 45. North America Calming and Sleeping Sales Market Share in Volume by Application in 2025 Figure 46. North America Calming and Sleeping Sales Market Share in Value by Application in 2025 Figure 47. Europe Calming and Sleeping Sales Market Share in Volume by Application in 2025 Figure 48. Europe Calming and Sleeping Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Calming and Sleeping Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Calming and Sleeping Sales Market Share in Value by Application in 2025 Figure 51. Latin America Calming and Sleeping Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Calming and Sleeping Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Calming and Sleeping Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Calming and Sleeping Sales Market Share in Value by Application in 2025 Figure 55. North America Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Calming and Sleeping Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Calming and Sleeping Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Calming and Sleeping Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Calming and Sleeping Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Calming and Sleeping Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Calming and Sleeping Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Calming and Sleeping Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Calming and Sleeping Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Calming and Sleeping Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Calming and Sleeping Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Calming and Sleeping Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Calming and Sleeping Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Calming and Sleeping Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Medications
  • Sleep Laboratories
  • Sleep Apnea Devices
  • Mattresses and Pillows
  • Prescriptions
  • Over-The-Counter (OTC)
Applications
  • Restless Leg Syndrome (RLS)
  • Narcolepsy
  • Sleepwalking
  • Bruxism
  • Insomnia
  • Sleep apnea
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Eli Lilly
  • AstraZeneca
  • Sunovion Pharmaceuticals
  • Roscoe Medical
  • Durect
  • Collegium Pharmaceutical
  • Cara Therapeutics
  • Acura Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Calming and Sleeping Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Calming and Sleeping Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Calming and Sleeping Market by Type
  6. 1.3.1 Medications
  7. 1.3.2 Sleep Laboratories
  8. 1.3.3 Sleep Apnea Devices
  9. 1.3.4 Mattresses and Pillows
  10. 1.3.5 Prescriptions
  11. 1.3.6 Over-The-Counter (OTC)
  12. 1.4 Global Calming and Sleeping Market Size by Type
  13. 1.4.1 Global Calming and Sleeping Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Calming and Sleeping Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Calming and Sleeping Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Calming and Sleeping Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Calming and Sleeping Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Calming and Sleeping Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Calming and Sleeping Industry Trends
  2. 2.2 Calming and Sleeping Industry Drivers
  3. 2.3 Calming and Sleeping Industry Opportunities and Challenges
  4. 2.4 Calming and Sleeping Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Calming and Sleeping Revenue (2021-2026)
  2. 3.2 Global Top Players by Calming and Sleeping Sales (2021-2026)
  3. 3.3 Global Top Players by Calming and Sleeping Price (2021-2026)
  4. 3.4 Global Calming and Sleeping Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Calming and Sleeping Major Company Production Sites & Headquarters
  6. 3.6 Global Calming and Sleeping Company, Product Type & Application
  7. 3.7 Global Calming and Sleeping Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Calming and Sleeping Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Calming and Sleeping Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Calming and Sleeping Tier 1, Tier 2, and Tier 3
4 Calming and Sleeping Regional Status and Outlook
  1. 4.1 Global Calming and Sleeping Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Calming and Sleeping Historic Market Size by Region
  3. 4.2.1 Global Calming and Sleeping Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Calming and Sleeping Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Calming and Sleeping Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Calming and Sleeping Forecasted Market Size by Region
  7. 4.3.1 Global Calming and Sleeping Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Calming and Sleeping Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Calming and Sleeping Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Calming and Sleeping by Application
  1. 5.1 Calming and Sleeping Market by Application
  2. 5.1.1 Restless Leg Syndrome (RLS)
  3. 5.1.2 Narcolepsy
  4. 5.1.3 Sleepwalking
  5. 5.1.4 Bruxism
  6. 5.1.5 Insomnia
  7. 5.1.6 Sleep apnea
  8. 5.2 Global Calming and Sleeping Market Size by Application
  9. 5.2.1 Global Calming and Sleeping Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Calming and Sleeping Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Calming and Sleeping Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Calming and Sleeping Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Calming and Sleeping Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Calming and Sleeping Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Calming and Sleeping Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Calming and Sleeping Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Sunovion Pharmaceuticals
  26. 6.5.1 Sunovion Pharmaceuticals Company Information
  27. 6.5.2 Sunovion Pharmaceuticals Business Overview
  28. 6.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
  30. 6.5.5 Sunovion Pharmaceuticals Recent Developments
  31. 6.6 Roscoe Medical
  32. 6.6.1 Roscoe Medical Company Information
  33. 6.6.2 Roscoe Medical Business Overview
  34. 6.6.3 Roscoe Medical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
  36. 6.6.5 Roscoe Medical Recent Developments
  37. 6.7 Durect
  38. 6.7.1 Durect Company Information
  39. 6.7.2 Durect Business Overview
  40. 6.7.3 Durect Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Durect Calming and Sleeping Product Portfolio
  42. 6.7.5 Durect Recent Developments
  43. 6.8 Collegium Pharmaceutical
  44. 6.8.1 Collegium Pharmaceutical Company Information
  45. 6.8.2 Collegium Pharmaceutical Business Overview
  46. 6.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
  48. 6.8.5 Collegium Pharmaceutical Recent Developments
  49. 6.9 Cara Therapeutics
  50. 6.9.1 Cara Therapeutics Company Information
  51. 6.9.2 Cara Therapeutics Business Overview
  52. 6.9.3 Cara Therapeutics Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
  54. 6.9.5 Cara Therapeutics Recent Developments
  55. 6.10 Acura Pharmaceuticals
  56. 6.10.1 Acura Pharmaceuticals Company Information
  57. 6.10.2 Acura Pharmaceuticals Business Overview
  58. 6.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
  60. 6.10.5 Acura Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Calming and Sleeping Sales by Country
  2. 7.1.1 North America Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Calming and Sleeping Sales by Country (2021-2026)
  4. 7.1.3 North America Calming and Sleeping Sales Forecast by Country (2027-2032)
  5. 7.2 North America Calming and Sleeping Market Size by Country
  6. 7.2.1 North America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Calming and Sleeping Market Size by Country (2021-2026)
  8. 7.2.3 North America Calming and Sleeping Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Calming and Sleeping Sales by Country
  2. 8.1.1 Europe Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Calming and Sleeping Sales by Country (2021-2026)
  4. 8.1.3 Europe Calming and Sleeping Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Calming and Sleeping Market Size by Country
  6. 8.2.1 Europe Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Calming and Sleeping Market Size by Country (2021-2026)
  8. 8.2.3 Europe Calming and Sleeping Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Calming and Sleeping Sales by Country
  2. 9.1.1 Asia-Pacific Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Calming and Sleeping Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Calming and Sleeping Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Calming and Sleeping Market Size by Country
  6. 9.2.1 Asia-Pacific Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Calming and Sleeping Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Calming and Sleeping Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Calming and Sleeping Sales by Country
  2. 10.1.1 South America Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Calming and Sleeping Sales by Country (2021-2026)
  4. 10.1.3 South America Calming and Sleeping Sales Forecast by Country (2027-2032)
  5. 10.2 South America Calming and Sleeping Market Size by Country
  6. 10.2.1 South America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Calming and Sleeping Market Size by Country (2021-2026)
  8. 10.2.3 South America Calming and Sleeping Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Calming and Sleeping Sales by Country
  2. 11.1.1 Middle East and Africa Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Calming and Sleeping Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Calming and Sleeping Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Calming and Sleeping Market Size by Country
  6. 11.2.1 Middle East and Africa Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Calming and Sleeping Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Calming and Sleeping Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Calming and Sleeping Value Chain Analysis
  2. 12.1.1 Calming and Sleeping Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Calming and Sleeping Production Mode & Process
  7. 12.2 Calming and Sleeping Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Calming and Sleeping Distributors
  10. 12.2.3 Calming and Sleeping Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research